Foundation Fighting Blindness Retinal Degeneration Fund has filed 4 insider transactions across 1 company since May 2025.
Most recent transaction: a sale of 1700000 shares of Opus Genetics, Inc. ($IRD) on May 18, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | Opus Genetics, Inc. | $IRD | Foundation Fighting Blindness Retinal Degeneration Fund | Other | S | Common Stock | 1700000 | $4.35 | 3,792,171.0000 | 70,636,887 | 30.95% | 2.41% |
| Dec. 9, 2025 | Opus Genetics, Inc. | $IRD | Foundation Fighting Blindness Retinal Degeneration Fund | Other | S | Common Stock | 4000000 | $2.15 | 5,492,171.0000 | 70,636,887 | 42.14% | 5.66% |
| May 5, 2025 | Opus Genetics, Inc. | $IRD | Foundation Fighting Blindness Retinal Degeneration Fund | Other | C | Common Stock | 6927419 | $0.00 | 9,492,171.0000 | 26,715,526 | 270.10% | 25.93% |
| May 5, 2025 | Opus Genetics, Inc. | $IRD | Foundation Fighting Blindness Retinal Degeneration Fund | Other | C | Series A Non-Voting Convertible Preferred Stock | 6927 | $0.00 | 0.0000 | 26,715,526 | 100.00% | 0.03% |